Skip to main content

Bellevue Group AG

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1674546 Zurich, V8

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,825,499
+$5,302,786 QoQ
Shares Held
55,682
+285.4% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#87
of 341 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. PTGX ranks #34 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,825,499 55,682
2026-03-31 $1,522,713 14,447
2025-12-31 $1,444,865 16,543
2025-09-30 $1,367,195 20,581
2025-06-30 $1,076,217 19,472
2025-03-31 $852,199 17,622
2024-12-31 $915,514 23,718
2024-09-30 $555,570 12,346
2024-06-30 $524,808 15,146
2024-03-31 $553,893 19,146
2023-12-31 $687,900 30,000
2023-09-30 $500,400 30,000